0
     

Report Added
Report already added
Meningococcal Vaccine Market - Global Outlook and Forecast 2021-2027

Meningococcal Vaccine Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Meningococcal Vaccine in global, including the following market information:
Global Meningococcal Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Meningococcal Vaccine Market Sales, 2016-2021, 2022-2027, (K Dose)
Global top five Meningococcal Vaccine companies in 2020 (%)
The global Meningococcal Vaccine market was valued at 257.8 million in 2020 and is projected to reach US$ 304 million by 2027, at a CAGR of 4.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meningococcal Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Meningococcal Vaccine Market Segment Percentages, By Type, 2020 (%)
Quadrivalent
Bivalent
Others

Global Meningococcal Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Meningococcal Vaccine Market Segment Percentages, By Application, 2020 (%)
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)

Global Meningococcal Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Meningococcal Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meningococcal Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Meningococcal Vaccine revenues share in global market, 2020 (%)
Key companies Meningococcal Vaccine sales in global market, 2016-2021 (Estimated), (K Dose)
Key companies Meningococcal Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
1 Introduction to Research & Analysis Reports
1.1 Meningococcal Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Meningococcal Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Meningococcal Vaccine Overall Market Size
2.1 Global Meningococcal Vaccine Market Size: 2021 VS 2027
2.2 Global Meningococcal Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Meningococcal Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Meningococcal Vaccine Players in Global Market
3.2 Top Global Meningococcal Vaccine Companies Ranked by Revenue
3.3 Global Meningococcal Vaccine Revenue by Companies
3.4 Global Meningococcal Vaccine Sales by Companies
3.5 Global Meningococcal Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Meningococcal Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Meningococcal Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Meningococcal Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Meningococcal Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Meningococcal Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Meningococcal Vaccine Market Size Markets, 2021 & 2027
4.1.2 Quadrivalent
4.1.3 Bivalent
4.1.4 Others
4.2 By Type - Global Meningococcal Vaccine Revenue & Forecasts
4.2.1 By Type - Global Meningococcal Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Meningococcal Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Meningococcal Vaccine Sales & Forecasts
4.3.1 By Type - Global Meningococcal Vaccine Sales, 2016-2021
4.3.2 By Type - Global Meningococcal Vaccine Sales, 2022-2027
4.3.3 By Type - Global Meningococcal Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Meningococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Meningococcal Vaccine Market Size, 2021 & 2027
5.1.2 Pneumonia
5.1.3 Meningitis
5.1.4 Bacteremia
5.1.5 Others (Arthritis, Conjunctivitis, Urethritis)
5.2 By Application - Global Meningococcal Vaccine Revenue & Forecasts
5.2.1 By Application - Global Meningococcal Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Meningococcal Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Meningococcal Vaccine Sales & Forecasts
5.3.1 By Application - Global Meningococcal Vaccine Sales, 2016-2021
5.3.2 By Application - Global Meningococcal Vaccine Sales, 2022-2027
5.3.3 By Application - Global Meningococcal Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Meningococcal Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Meningococcal Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Meningococcal Vaccine Revenue & Forecasts
6.2.1 By Region - Global Meningococcal Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Meningococcal Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Meningococcal Vaccine Sales & Forecasts
6.3.1 By Region - Global Meningococcal Vaccine Sales, 2016-2021
6.3.2 By Region - Global Meningococcal Vaccine Sales, 2022-2027
6.3.3 By Region - Global Meningococcal Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Meningococcal Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Meningococcal Vaccine Sales, 2016-2027
6.4.3 US Meningococcal Vaccine Market Size, 2016-2027
6.4.4 Canada Meningococcal Vaccine Market Size, 2016-2027
6.4.5 Mexico Meningococcal Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Meningococcal Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Meningococcal Vaccine Sales, 2016-2027
6.5.3 Germany Meningococcal Vaccine Market Size, 2016-2027
6.5.4 France Meningococcal Vaccine Market Size, 2016-2027
6.5.5 U.K. Meningococcal Vaccine Market Size, 2016-2027
6.5.6 Italy Meningococcal Vaccine Market Size, 2016-2027
6.5.7 Russia Meningococcal Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Meningococcal Vaccine Market Size, 2016-2027
6.5.9 Benelux Meningococcal Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Meningococcal Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Meningococcal Vaccine Sales, 2016-2027
6.6.3 China Meningococcal Vaccine Market Size, 2016-2027
6.6.4 Japan Meningococcal Vaccine Market Size, 2016-2027
6.6.5 South Korea Meningococcal Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Meningococcal Vaccine Market Size, 2016-2027
6.6.7 India Meningococcal Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Meningococcal Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Meningococcal Vaccine Sales, 2016-2027
6.7.3 Brazil Meningococcal Vaccine Market Size, 2016-2027
6.7.4 Argentina Meningococcal Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Meningococcal Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Meningococcal Vaccine Sales, 2016-2027
6.8.3 Turkey Meningococcal Vaccine Market Size, 2016-2027
6.8.4 Israel Meningococcal Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Meningococcal Vaccine Market Size, 2016-2027
6.8.6 UAE Meningococcal Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Meningococcal Vaccine Major Product Offerings
7.1.4 Novartis Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Meningococcal Vaccine Major Product Offerings
7.2.4 GSK Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Meningococcal Vaccine Major Product Offerings
7.3.4 Merck Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 CSL
7.4.1 CSL Corporate Summary
7.4.2 CSL Business Overview
7.4.3 CSL Meningococcal Vaccine Major Product Offerings
7.4.4 CSL Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 CSL Key News
7.5 Baxter
7.5.1 Baxter Corporate Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Meningococcal Vaccine Major Product Offerings
7.5.4 Baxter Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Baxter Key News
7.6 JN International Medical Corporation
7.6.1 JN International Medical Corporation Corporate Summary
7.6.2 JN International Medical Corporation Business Overview
7.6.3 JN International Medical Corporation Meningococcal Vaccine Major Product Offerings
7.6.4 JN International Medical Corporation Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 JN International Medical Corporation Key News
7.7 Serum Institute of India
7.7.1 Serum Institute of India Corporate Summary
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Meningococcal Vaccine Major Product Offerings
7.4.4 Serum Institute of India Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Serum Institute of India Key News
7.8 Bio-Med
7.8.1 Bio-Med Corporate Summary
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Meningococcal Vaccine Major Product Offerings
7.8.4 Bio-Med Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Bio-Med Key News
7.9 China National Biotec Group
7.9.1 China National Biotec Group Corporate Summary
7.9.2 China National Biotec Group Business Overview
7.9.3 China National Biotec Group Meningococcal Vaccine Major Product Offerings
7.9.4 China National Biotec Group Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.9.5 China National Biotec Group Key News
7.10 Hualan Bio
7.10.1 Hualan Bio Corporate Summary
7.10.2 Hualan Bio Business Overview
7.10.3 Hualan Bio Meningococcal Vaccine Major Product Offerings
7.10.4 Hualan Bio Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.10.5 Hualan Bio Key News
7.11 Walvax
7.11.1 Walvax Corporate Summary
7.11.2 Walvax Meningococcal Vaccine Business Overview
7.11.3 Walvax Meningococcal Vaccine Major Product Offerings
7.11.4 Walvax Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.11.5 Walvax Key News
7.12 Zhifei
7.12.1 Zhifei Corporate Summary
7.12.2 Zhifei Meningococcal Vaccine Business Overview
7.12.3 Zhifei Meningococcal Vaccine Major Product Offerings
7.12.4 Zhifei Meningococcal Vaccine Sales and Revenue in Global (2016-2021)
7.12.5 Zhifei Key News
8 Global Meningococcal Vaccine Production Capacity, Analysis
8.1 Global Meningococcal Vaccine Production Capacity, 2016-2027
8.2 Meningococcal Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Meningococcal Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Meningococcal Vaccine Supply Chain Analysis
10.1 Meningococcal Vaccine Industry Value Chain
10.2 Meningococcal Vaccine Upstream Market
10.3 Meningococcal Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Meningococcal Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Meningococcal Vaccine in Global Market
Table 2. Top Meningococcal Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Meningococcal Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Meningococcal Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Meningococcal Vaccine Sales by Companies, (K Dose), 2016-2021
Table 6. Global Meningococcal Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Meningococcal Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Meningococcal Vaccine Product Type
Table 9. List of Global Tier 1 Meningococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Meningococcal Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
Table 15. By Type - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
Table 16. By Application – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
Table 20. By Application - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
Table 21. By Region – Global Meningococcal Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Meningococcal Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Meningococcal Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Meningococcal Vaccine Sales (K Dose), 2016-2021
Table 25. By Region - Global Meningococcal Vaccine Sales (K Dose), 2022-2027
Table 26. By Country - North America Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Meningococcal Vaccine Sales, (K Dose), 2016-2021
Table 29. By Country - North America Meningococcal Vaccine Sales, (K Dose), 2022-2027
Table 30. By Country - Europe Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Meningococcal Vaccine Sales, (K Dose), 2016-2021
Table 33. By Country - Europe Meningococcal Vaccine Sales, (K Dose), 2022-2027
Table 34. By Region - Asia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Meningococcal Vaccine Sales, (K Dose), 2016-2021
Table 37. By Region - Asia Meningococcal Vaccine Sales, (K Dose), 2022-2027
Table 38. By Country - South America Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Meningococcal Vaccine Sales, (K Dose), 2016-2021
Table 41. By Country - South America Meningococcal Vaccine Sales, (K Dose), 2022-2027
Table 42. By Country - Middle East & Africa Meningococcal Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Meningococcal Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Meningococcal Vaccine Sales, (K Dose), 2016-2021
Table 45. By Country - Middle East & Africa Meningococcal Vaccine Sales, (K Dose), 2022-2027
Table 46. Novartis Corporate Summary
Table 47. Novartis Meningococcal Vaccine Product Offerings
Table 48. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. GSK Corporate Summary
Table 50. GSK Meningococcal Vaccine Product Offerings
Table 51. GSK Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. Merck Corporate Summary
Table 53. Merck Meningococcal Vaccine Product Offerings
Table 54. Merck Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. CSL Corporate Summary
Table 56. CSL Meningococcal Vaccine Product Offerings
Table 57. CSL Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 58. Baxter Corporate Summary
Table 59. Baxter Meningococcal Vaccine Product Offerings
Table 60. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 61. JN International Medical Corporation Corporate Summary
Table 62. JN International Medical Corporation Meningococcal Vaccine Product Offerings
Table 63. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 64. Serum Institute of India Corporate Summary
Table 65. Serum Institute of India Meningococcal Vaccine Product Offerings
Table 66. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 67. Bio-Med Corporate Summary
Table 68. Bio-Med Meningococcal Vaccine Product Offerings
Table 69. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 70. China National Biotec Group Corporate Summary
Table 71. China National Biotec Group Meningococcal Vaccine Product Offerings
Table 72. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 73. Hualan Bio Corporate Summary
Table 74. Hualan Bio Meningococcal Vaccine Product Offerings
Table 75. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 76. Walvax Corporate Summary
Table 77. Walvax Meningococcal Vaccine Product Offerings
Table 78. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 79. Zhifei Corporate Summary
Table 80. Zhifei Meningococcal Vaccine Product Offerings
Table 81. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 82. Meningococcal Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2019-2021 (K Dose)
Table 83. Global Meningococcal Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 84. Global Meningococcal Vaccine Production by Region, 2016-2021 (K Dose)
Table 85. Global Meningococcal Vaccine Production by Region, 2022-2027 (K Dose)
Table 86. Meningococcal Vaccine Market Opportunities & Trends in Global Market
Table 87. Meningococcal Vaccine Market Drivers in Global Market
Table 88. Meningococcal Vaccine Market Restraints in Global Market
Table 89. Meningococcal Vaccine Raw Materials
Table 90. Meningococcal Vaccine Raw Materials Suppliers in Global Market
Table 91. Typical Meningococcal Vaccine Downstream
Table 92. Meningococcal Vaccine Downstream Clients in Global Market
Table 93. Meningococcal Vaccine Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Meningococcal Vaccine Segment by Type
Figure 2. Meningococcal Vaccine Segment by Application
Figure 3. Global Meningococcal Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Meningococcal Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Meningococcal Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Meningococcal Vaccine Sales in Global Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Meningococcal Vaccine Revenue in 2020
Figure 9. By Type - Global Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Meningococcal Vaccine Price (USD/Dose), 2016-2027
Figure 12. By Application - Global Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Meningococcal Vaccine Price (USD/Dose), 2016-2027
Figure 15. By Region - Global Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 19. US Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 33. China Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Meningococcal Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Meningococcal Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Meningococcal Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Meningococcal Vaccine Production Capacity (K Dose), 2016-2027
Figure 49. The Percentage of Production Meningococcal Vaccine by Region, 2020 VS 2027
Figure 50. Meningococcal Vaccine Industry Value Chain
Figure 51. Marketing Channels

Report Title: Meningococcal Vaccine Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW